English  |  正體中文  |  简体中文  |  Items with full text/Total items : 54371/62179 (87%)
Visitors : 8913685      Online Users : 102
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTHU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    National Tsing Hua University Institutional Repository > 科技管理學院  > 經營管理碩士在職專班 > 博碩士論文  >  全球動物藥廠併購整合策略: 以B公司為例探討區域併購後行銷策略

    Please use this identifier to cite or link to this item: http://nthur.lib.nthu.edu.tw/dspace/handle/987654321/86247

    Title: 全球動物藥廠併購整合策略: 以B公司為例探討區域併購後行銷策略
    Authors: 蔡昇達
    Tsai, Sheng-Ta
    Description: GH02101076506
    Date: 2014
    Keywords: 動物保健
    Animal Health
    Abstract: 各類大型跨國企業為達其營運目標,進行併購(Mergers & Acquisition; M&A)或是企業分割(Spin-off) 相當的常見,但可以見得的,製藥產業發生合資、併購或分割等行為的比例,遠較其他產業為高。除了製藥業本身的特性之外,當前社會經濟的活絡程度、各國主管機關法規的限縮、研發耗時且花費金額甚鉅、面臨專利屆期的壓力等因素,造成現今製藥產業巨擘之間的相互併購行為層出不窮,其衍伸的問題包括壟斷、過度多角化、議價能力上升、環境保護議題等,除了影響旗下子公司股東及員工甚鉅,更深深地影響消費者與普羅大眾之權益。


    It is quite common to see various large multinationals to implement the mergers & acquisition (M&A) or spin-off to achieve their business objectives. In the past, the proportion of joint venture or spin-off occurred in pharmaceutical industry are getting higher and higher than other industries. In addition to the characteristics of the pharmaceutical industry itself, the dynamic of current socio-economic, national regulatory authorities is getting strict and rigorous, and the research and development is always spending hugely time-consuming and facing the pressure of the expiration of patents or other factors. The currently results, pharmaceutical industry giants execute mergers & acquisitions between each other. But extended the endless problems of monopoly (antitrust issue), excessive diversification, the force of bargaining to consumers is rising and environmental issue. Not only being huge influence of shareholders and employees in belonged subsidiary but also deeply affect the interests of consumer and the right of general public.

    The animal health companies are mostly attached to the human pharmaceutical industry, although the proportion of the parent corporation isn’t so high, but cause many problems of animal welfare and health, even impact on food supply, protein sources and human health, can cause in a certain of influence on human society as well. The purpose of study is to elaborate the issues of mergers and acquisitions on the pharmaceutical industry. Then the present study analyzes the history of development and behavior of mergers & acquisition activity of top three by case study method.

    Finally, taking the process of joint venture and M&A of B group in Taiwan for example to make the description and compared. The content recount the back ground of animal health and biotech industry. Most of Taiwanese plants are facing the difficulties in the limited market and situation of lack the technical and financial support. But their competitiveness will get greatly enhanced by import the production management system if receive the investment or joint ventures from foreigner firms once and will describe the process detailed in this study.
    URI: http://nthur.lib.nthu.edu.tw/dspace/handle/987654321/86247
    Source: http://thesis.nthu.edu.tw/cgi-bin/gs/hugsweb.cgi?o=dnthucdr&i=sGH02101076506.id
    Appears in Collections:[經營管理碩士在職專班] 博碩士論文

    Files in This Item:

    File SizeFormat
    GH02101076506.pdf235KbAdobe PDF157View/Open


    SFX Query


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback